IL-17 as a future therapeutic target for rheumatoid arthritis.
about
T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseT Cell Migration in Rheumatoid ArthritisRheumatoid arthritis: a role for immunosenescence?Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitisGlycyrol suppresses collagen-induced arthritis by regulating autoimmune and inflammatory responsesExposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritisTherapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitisEnhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritisIK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activationThe oxidative stress theory of disease: levels of evidence and epistemological aspects.Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss.Rationale and early clinical data on IL-17 blockade in psoriasis.Microbiota in T-cell homeostasis and inflammatory diseasesZingiber officinale: A Potential Plant against Rheumatoid Arthritis.Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritisDifferential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responsesThe development of inducible bronchus-associated lymphoid tissue depends on IL-17.Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression.Interleukin-17 enhances immunosuppression by mesenchymal stem cellsIL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generationRodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritisDRB1*0402 may influence arthritis by promoting naive CD4+ T-cell differentiation in to regulatory T cells.Hydrogels and scaffolds for immunomodulationRORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cellsSystemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritisLocal administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patientInhibition of IL-17A suppresses enhanced-tumor growth in low dose pre-irradiated tumor bedsThe protective effects of chronic intermittent hypobaric hypoxia pretreatment against collagen-induced arthritis in rats.Serum proteomic profiling in granumomatosis with polyangiitis using two-dimensional gel electrophoresis along with matrix assisted laser desorption ionization time of flight mass spectrometry.Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells.Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis.Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG miceThe effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema.Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model.
P2860
Q24609737-3B6B57C3-6C3A-4CE0-8876-11F73268C20FQ26797338-9B7EBCBC-5493-4C2B-9798-0FB8FC5B685DQ27693905-2BC8CEC9-7CB4-4D00-8B32-C9B23D154136Q28080991-B43E848F-3D74-4E10-980A-49B0D700C39DQ28540896-F06C068C-E65F-40D3-BB6D-10DD8430C3BBQ28728570-79BD75C2-35A9-4C01-8624-0DA4D1ACD915Q28740568-761A5F37-4455-44CA-9DBB-F14EDD5A6DBEQ28744262-B5E486E3-6680-4FBC-9925-09428B92D060Q28817694-DC40EAE6-60E7-447C-8CA4-15FF8BED79D7Q30489579-7B8A26FA-C932-4031-8C80-8DA8366AB3F5Q30583336-0B8B5295-FD3E-4C1D-A2AC-6C4E7C8AC1E8Q30658185-C46C3291-90E0-46E3-B53B-0C06B0125C03Q33754038-CCE5C6F5-2637-420D-BF15-AC258F2FFCD1Q33759109-A87E7FEA-C0A1-4628-A0B5-88929D796273Q33810570-5176BB1A-4B46-44BE-BBC4-E4B836BAB63CQ33999639-F4280526-FBCB-44C8-967A-9038B2DD53EBQ34061724-A12E2210-CA5D-4B22-8B90-D6CE1052E2B7Q34169114-0F52A418-D8BA-4278-8B96-B3FF9B9CFE4CQ34170674-D6D85D3F-583E-49F2-A137-5C88E598AFE8Q34191942-8FCA5AA9-85F1-4838-BD1E-C38DA0754B24Q34320329-C46E8B84-1624-42AA-8CB7-BC0C42898F18Q34346316-45F18127-9203-486B-AEDB-C5716CB2DA9AQ34413472-05455011-6B19-4019-A636-1310B1746550Q34440569-58E50D78-53FF-4924-A1E5-ACB7ACAE94F5Q34497135-D13905AF-A309-4B61-AA62-E2304C808027Q34509459-96CD9F69-04E8-487F-8B56-D617E761089AQ34516919-6CD0A1AB-AC70-4E9F-8C75-6DABD38AA6EFQ34725541-61C1CF38-02DF-4031-B8DD-34A4CA2D4623Q34831560-EE0673B5-D68A-4FB1-B46F-8BAC2A57E01AQ35133083-3D5DD818-94B2-42DB-B764-F821E4333712Q35157400-DF7C9139-D69A-4BF6-A07F-3B35ACDE46F9Q35173936-AE93DB57-3529-4F63-8A89-45909CDC0C2EQ35236833-F00D3C0F-97B1-4238-BB5F-FC2527B06825Q35314518-8ECE7FBB-0E6C-4795-B40B-D5F35BF0027BQ35371889-A76DBD2D-BF1C-45C2-8337-3656E079FC82Q35381281-EC0ED470-7063-4E36-938B-03ABC043A426Q35494888-50B33DBE-2C99-4123-9809-963A977582E6Q35557836-EEFFFC2B-8BC3-4699-8008-CE8230B1A3E6Q35631906-C8BF5FCA-F5DE-4491-9D98-264F2440E99FQ35760186-5103B9DF-3B1D-47B4-9A7A-8088F2E0690E
P2860
IL-17 as a future therapeutic target for rheumatoid arthritis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IL-17 as a future therapeutic target for rheumatoid arthritis.
@ast
IL-17 as a future therapeutic target for rheumatoid arthritis.
@en
IL-17 as a future therapeutic target for rheumatoid arthritis.
@nl
type
label
IL-17 as a future therapeutic target for rheumatoid arthritis.
@ast
IL-17 as a future therapeutic target for rheumatoid arthritis.
@en
IL-17 as a future therapeutic target for rheumatoid arthritis.
@nl
prefLabel
IL-17 as a future therapeutic target for rheumatoid arthritis.
@ast
IL-17 as a future therapeutic target for rheumatoid arthritis.
@en
IL-17 as a future therapeutic target for rheumatoid arthritis.
@nl
P2860
P356
P1476
IL-17 as a future therapeutic target for rheumatoid arthritis.
@en
P2093
Wim B van den Berg
P2860
P2888
P304
P356
10.1038/NRRHEUM.2009.179
P407
P577
2009-10-01T00:00:00Z
P6179
1052243851